On Monday, Moderna (NASDAQ: MRNA) stock rallied by over 10% after the company said that its Covid-19 vaccine - which is based on messenger RNA technology - was 94.5% effective based on preliminary data. Investors have good reason to be optimistic about Moderna for multiple reasons...
On Monday, Moderna (NASDAQ: MRNA) stock rallied by over 10% after the company said that its Covid-19 vaccine - which is based on messenger RNA technology - was 94.5% effective based on preliminary data. Investors have good reason to be optimistic about Moderna for multiple reasons...
Share this Article
Comment on this Article
Recommended
Please to comment